Explore chapters and articles related to this topic
The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration
Published in Platelets, 2022
Martine Baumann, Benoît Lack, Isabelle Guillaumat, Mark J. Murphy, Markus A. Riederer
Constant concentrations of [3H]-selatogrel (3, 10, 30 and 100 nM, respectively) were incubated with a concentration range of ADP (0.03 μM up to 316 μM). With increasing concentration of ADP, binding of [3H]-selatogrel to the P2Y12 receptor was dose-dependently reduced. In addition, an increase of [3H]-selatogrel concentration resulted in a right-shift of the ADP-inhibition curves toward higher concentrations of ADP (Figure 1c). Analysis of this data with a Schild regression (log [3H]-selatogrel concentration versus log [concentration ratio-1]) [35,36] revealed a linear correlation with a slope of 1.07 (Schild equation: y = 1.07x +8.9) and a correlation factor of 0.95, confirming that [3H]-selatogrel is a competitive antagonist of ADP binding to the P2Y12 receptor (Figure 1d).